The Filing Desk

eHealth

EHTH · Nasdaq · Financials · Financials, fiscal 2016 to 2025

EHTH · Last close · November 19, 2026
$0.34
Value eHealth yourself

eHealth's revenue rose 4.1% to $554 million in fiscal 2025. Its operating margin was 12.0%, up from 4.4% a year earlier. Free cash flow was −$28 million. The diluted share count rose 3.9%.

EHEALTH, INC. Latest fiscal year ended December 31, 2025 10-K filed February 26, 2026 · 0001333493-26-000010 Updated
Revenue
$554M
4.1%
Operating margin
12.0%
7.6 pts
Net income
$40M
298.2%
Free cash flow
−$28M
 
Return on capital
7.5%
5.4 pts
Market cap
$11M
Nov 19 close
P/E
—
Loss: no P/E

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

Charts show fiscal years, from the 10-K filings.

What eHealth does

eHealth is a licensed health insurance agency that helps people in the United States compare and sign up for health plans, mostly Medicare plans for people 65 and older. Shoppers can use its websites on their own, call one of its licensed agents, which it calls benefit advisors, or mix the two through online chat. It offers thousands of plans from over 180 insurers, including Medicare Advantage, Medicare Supplement and prescription drug plans, as well as individual, family, small business, dental and vision coverage.

The service is free to consumers. eHealth is paid by the insurers, mostly through commissions on the policies it sells, often every month for as long as a member keeps the plan. It also earns fees for advertising, enrollment work and licensing its technology to insurers. It does not take on insurance risk itself. The Medicare segment made up approximately 96% of revenue in 2025; the rest came from the Employer and Individual segment. Its competitors include government-run insurance exchanges, insurers selling directly, other online brokers and local insurance agents.

Much of its sales come in the fall, during Medicare's yearly enrollment period. At the end of 2025 eHealth had 1,665 regular full-time employees, most of them in customer care and enrollment, including 163 at its subsidiary in China.

Its biggest risks, as it describes them

  • Insurers can end or change their agency deals on short notice, and a few of them bring in much of its revenue.
  • Complex and changing Medicare marketing rules, and legal proceedings or government inquiries over its sales practices.
  • Members who drop their plans early, cutting the commissions it expects to receive over time.
  • Its heavy reliance on the fall Medicare enrollment season, and on hiring and keeping licensed agents in time for it.
  • Competition from government-run exchanges, insurers and other agents and brokers.
From eHealth's annual report on Form 10-K, filed February 26, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

From fiscal 2016 to 2020, earnings per share grew 202.7% a year and net income 250.7% a year, as new shares raised the share count by 48% and diluted each share's earnings. eHealth then lost money in fiscal 2021, 2022 and 2023.

Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments1231441228277
Debt incl. finance leases0666868113
Net debt (negative means net cash)−123−78−54−1436
Net debt to EBITDA———−0.5x0.5x
Debt to equity0.0x0.1x0.1x0.1x0.2x
Interest coverage−148.7x−13.5x−2.6x2.1x6.2x
Current ratio5.4x6.6x4.9x3.7x3.4x
Quick ratio5.4x6.6x4.9x3.7x3.4x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Projections

Project eHealth's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.

What eHealth says to expect

  • Full year 2026: total revenueTotal revenue is expected to be in the range of $405.0 million to $445.0 million.
  • Full year 2026: GAAP net incomeGAAP net income is expected to be in the range of $8.0 million to $25.0 million.
  • Full year 2026: adjusted EBITDAAdjusted EBITDA (1) is expected to be in the range of $55.0 million to $75.0 million.
  • Full year 2026: operating cash flowOperating cash flow is expected to be in the range of $(10.0) million to $12.0 million.
The company's own words, from its earnings release (Form 8-K, Exhibit 99), filed November 4, 2026. They are its expectations, not ours, and not a forecast or price target from The Filing Desk. Replaced when the next release is out.

Insider trades

Over the 12 months between November 20, 2025 and November 19, 2026, 2 insiders bought $297,647 of eHealth shares on the open market, and 1 insider sold $81,679, all of it under trading plans set up in advance.

Buys and sells by month
US$ millions, open-market purchases (up) and sales (down) by officers, directors and 10% owners in each month.
BoughtSold
DateInsiderTradeSharesPriceValueFiling
Sep 1, 2026Francis S Soistman JrDirectorSold plan37,297$1.05$39,162Form 4
Aug 31, 2026Francis S Soistman JrDirectorSold plan37,296$1.14$42,517Form 4
Mar 6, 2026John Joseph DolanChief Financial OfficerBought25,000$1.53$38,250Form 4
Feb 27, 2026Derrick A DukeChief Executive Officer, DirectorBought187,969$1.38$259,397Form 4
Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score3 of 95 of 94 of 9
Rule of 409.8%13.7%−0.9%
Altman Z''4.684.343.81
Accruals ratio−1.9%2.5%5.4%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positiveFailPassPass
Cash from operations is positiveFailFailFail
Return on assets rosePassPassPass
Cash from operations exceeds net incomePassFailFail
Debt fell relative to assetsFailPassFail
Current ratio roseFailFailFail
Share count didn't riseFailFailFail
Gross margin roseFailPassPass
Revenue rose relative to assetsPassPassPass
F-score3 of 95 of 94 of 9
Companies that report no gross profit are scored on the other eight.

Compare

Put eHealth side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
eHealthFY254.1%12.0%−5.0%7.5%0.5x4
AIFUFY25−58.2%−7.0%−3.5%———Compare
Ethos TechnologiesFY2552.0%18.8%9.0%———Compare
Goosehead InsuranceFY2516.1%20.4%23.6%75.5%3.0x5Compare
XChange TEC.INCFY2526.7%−197.2%————Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

10 years of figures

Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue193191251506583538405453532554
Revenue growth2.0%−1.4%31.8%101.4%15.1%−7.7%−24.7%11.7%17.6%4.1%
Gross profit192190250504579536404159208241
Research and development987891012141214
Operating income3−1038153−126−103−292466
Net income02506745−104−89−281040
Diluted EPS (US$)0.021.330.012.731.68−4.59−4.36−2.37−1.19−0.34
Diluted shares (millions)18192024272727282930
Cash flow
Cash from operations4−16−3−72−108−163−27−7−18−25
Capital expenditure2247840222
Free cash flow2−17−8−78−116−166−27−9−20−28
Dividends paid0000000000
Share buybacks0000000000
Acquisitions00150000000
Stock-based compensation7101223253320232015
Balance sheet at fiscal year end
Cash and short-term investments62401324931231441228277
Debt incl. finance leases—05000666868113
Total assets1093594397421,0401,1491,1131,1131,1551,262
Total liabilities−14372136214202167198209230289
Shareholders' equity252287303527838750651606588592
Margins and ratios
Gross margin99.5%99.7%99.5%99.5%99.3%99.6%99.6%35.1%39.1%43.5%
Operating margin1.5%−5.0%1.0%16.1%9.2%−23.4%−25.3%−6.4%4.4%12.0%
Net margin0.2%13.3%0.1%13.2%7.8%−19.4%−21.9%−6.2%1.9%7.2%
Free cash flow margin1.1%−9.1%−3.1%−15.4%−19.8%−30.9%−6.7%−1.9%−3.8%−5.0%
Rule of 40 (growth + FCF margin)3.1%−10.5%28.7%85.9%−4.7%−38.6%−31.4%9.8%13.7%−0.9%
Return on capital——0.5%16.3%7.2%−14.5%−13.5%−4.1%2.2%7.5%
Return on equity0.1%9.4%0.1%16.1%6.7%−13.2%−12.7%−4.5%1.7%6.8%
Return on assets0.3%10.9%0.1%11.3%5.1%−9.5%−7.8%−2.5%0.9%3.3%
Net debt to EBITDA——−1.1x−0.3x−1.4x———−0.5x0.5x
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: eHealth's Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with eHealth.